The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $69.89

Today's change+0.29 +0.42%
Updated May 24 2:06 PM EDT. Delayed by at least 15 minutes.
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $69.89

Today's change+0.29 +0.42%
Updated May 24 2:06 PM EDT. Delayed by at least 15 minutes.

ResMed Inc crosses above 50-day moving average

ResMed Inc is up today by (U.S.)$0.29 or 0.42% to (U.S.)$69.89 and crossing above its 50-day moving average. Over the last five days, shares have gained 3.30% and are currently 4.86% off of the 52-week high. Shares have outperformed the S&P 500 by 3.04% during the last year.

Key company metrics

  • Open(U.S.) $69.81
  • Previous close(U.S.) $69.60
  • High(U.S.) $70.15
  • Low(U.S.) $69.61
  • Bid / Ask(U.S.) $69.83 / (U.S.) $69.92
  • YTD % change+12.63%
  • Volume148,310
  • Average volume (10-day)460,664
  • Average volume (1-month)745,611
  • Average volume (3-month)784,482
  • 52-week range(U.S.) $56.59 to (U.S.) $73.46
  • Beta0.82
  • Trailing P/E29.79×
  • P/E 1 year forward24.74×
  • Forward PEG2.32×
  • Indicated annual dividend(U.S.) $1.32
  • Dividend yield1.89%
  • Trailing EPS(U.S.) $2.35
Updated May 24 2:06 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.55%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue514530465519
Total other revenue--------
Total revenue514530465519
Gross profit300309269301
Total cost of revenue214221196217
Total operating expense407434371400
Selling / general / administrative138139129136
Research & development35383434
Depreciation / amortization11121213
Interest expense (income), net operating--------
Unusual expense (income)823--0
Other operating expenses, total--------
Operating income1079794119
Interest income (expense), net non-operating-------11
Gain (loss) on sale of assets--------
Other--------
Income before tax1089693117
Income after tax88777693
Income tax, total20191724
Net income88777693
Total adjustments to net income--------
Net income before extra. items88777693
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items88777693
Inc. avail. to common incl. extra. items88777693
Diluted net income88777693
Dilution adjustment----00
Diluted weighted average shares143142142142
Diluted EPS excluding extraordinary itemsvalue per share0.620.540.540.66
Dividends per sharevalue per share0.330.330.330.30
Diluted normalized EPSvalue per share0.660.670.540.66